Mutations in the glucokinase gene are a major cause of maturity-onset
diabetes of the young. To evaluate the contribution of this gene to th
e development of late-onset NIDDM, linkage analyses between DNA polymo
rphisms at the glucokinase locus and NIDDM were performed in 79 multig
enerational French families. in addition, all exons and the islet prom
oter region of glucokinase gene from 1 affected member from each famil
y as well as from 17 unrelated women with previous gestational diabete
s were amplified by polymerase chain reaction and screened for mutatio
ns by single-strand conformational polymorphism and DNA sequencing. Li
nkage of glucokinase and NIDDM was significantly rejected under all mo
dels tested. However, in 1 family, the lod score was 2.30, and we foun
d a nucleotide substitution at the position -30 in the islet promoter
region that cosegregated with diabetes. The proband of this family was
a gestational diabetic individual. No other mutation in glucokinase w
as found in the 79 NIDDM families. We identified a missense mutation (
TGG257 --> CGG257) in exon 7 of glucokinase gene from 1 of 17 women wi
th gestational diabetes, which was present in all diabetic members of
her family. This family is likely to be a cryptic maturity-onset diabe
tes of the young, as 4 younger members, carrying this mutation, were s
ubsequently found to be hyperglycemic. In conclusion, no evidence was
obtained to incriminate glucokinase as a major gene for late age of on
set NIDDM. Diabetic families with mutations in glucokinase must be car
efully investigated, to differentiate cryptic maturity-onset diabetes
of the young from late-onset NIDDM. Furthermore, pregnancy reveals dia
betes in women carrying a glucokinase defect.